Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translatable electrophysiological and behavioral abnormalities in a humanized model of SYNGAP1-disorder.

Molecular psychiatry·2026
Same author

Temporal single-cell atlas of full-length Huntington's disease mouse model defines stage-specific signatures of corticostriatal dysfunction.

Molecular neurodegeneration·2026
Same author

Optimized AAV capsids robustly transduce airway epithelial cells.

bioRxiv : the preprint server for biology·2026
Same author

Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector Delivery.

The New England journal of medicine·2026
Same author

Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platform.

American journal of human genetics·2026
Same author

Temporal single-cell atlas of full-length Huntington's disease mouse model defines stage-specific signatures of corticostriatal dysfunction.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Oct 2, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.3K

Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical Studies.

Sophie St-Cyr1, Alicia R Smith1, Beverly L Davidson1,2

  • 1The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Journal of Huntington'S Disease
|February 25, 2022
PubMed
Summary

This study identifies optimal behavioral tests for Huntington's disease (HD) mouse models. Researchers can now select the best tests and sample sizes for preclinical studies to detect treatment efficacy in HD.

Keywords:
Huntington’s diseasedescending rodmotor activitymuscle strengthnarrow beamrotarod test

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.3K

Related Experiment Videos

Last Updated: Oct 2, 2025

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.3K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Huntington's disease (HD) is a genetic disorder caused by CAG repeats in the Huntingtin (HTT) gene.
  • Mouse models are crucial for developing HD therapies, with various models available (transgenic, knock-in, full-length).
  • These models exhibit distinct disease onset, symptoms, and progression, necessitating careful selection for research.

Purpose of the Study:

  • To recommend the most effective behavioral tests for assessing disease progression in three distinct HD mouse models.
  • To guide researchers in choosing appropriate tests and sample sizes for preclinical HD research.

Main Methods:

  • Evaluated N171-82Q transgenic, zQ175 knock-in, and BACHD full-length HD mouse models.
  • Administered a comprehensive battery of behavioral tests across early, mid-, and late disease stages.
  • Compared observed phenotypes with existing literature.

Main Results:

  • Identified the most effective behavioral tests and optimal sample sizes for each HD mouse model at different disease stages.
  • Highlighted options for early detection of motor deficits, reducing testing time and training requirements.
  • Contrasted and compared model-specific phenotypes.

Conclusions:

  • Provides essential guidance for selecting appropriate HD mouse models and behavioral tests for preclinical research.
  • Enables sensitive and accurate detection of treatment efficacy in Huntington's disease research.
  • Facilitates informed decisions on sample sizes and testing strategies to advance HD therapy development.